The Automated Cell Shakers Market was valued at USD 698.9 million in 2024, and is projected to reach USD 1.05 billion by 2030, rising at a CAGR of 7.10%. This expansion is largely driven by the rising demand for high-throughput biological research. Laboratories and research institutions increasingly adopt automated systems to enhance workflow efficiency and minimize manual errors. Automated cell shakers enable uniform cell growth and precise environmental control, which are crucial in cell-based assays and culture processes. The need for reproducible experimental conditions pushes facilities to replace manual methods with automated technologies. This shift strengthens the demand for cell shakers in academic and industrial research settings.
Biopharmaceutical companies contribute significantly to market expansion through continuous drug development and biologics production investments. These firms require scalable and consistent cell culture processes to support preclinical and clinical testing. Automated cell shakers offer time-saving benefits and ensure consistent mixing, essential for producing quality biological products. Companies integrate automated systems to maintain regulatory compliance and production efficiency as the biopharmaceutical pipeline expands. This trend directly impacts automated cell shaker sales growth across global markets.
The growth of personalized medicine and regenerative therapies creates new opportunities for automated cell shaker technologies. Stem cell research, tissue engineering, and gene therapy rely on stable and controlled culture environments. Automated systems help standardize these processes, ensuring better outcomes and scalability for advanced treatments. Moreover, automation allows labs to handle more samples, reducing turnaround time and increasing productivity. As precision medicine gains traction, automated cell shakers are becoming essential tools in clinical and translational research workflows.
This product will be delivered within 1-3 business days.
Biopharmaceutical companies contribute significantly to market expansion through continuous drug development and biologics production investments. These firms require scalable and consistent cell culture processes to support preclinical and clinical testing. Automated cell shakers offer time-saving benefits and ensure consistent mixing, essential for producing quality biological products. Companies integrate automated systems to maintain regulatory compliance and production efficiency as the biopharmaceutical pipeline expands. This trend directly impacts automated cell shaker sales growth across global markets.
The growth of personalized medicine and regenerative therapies creates new opportunities for automated cell shaker technologies. Stem cell research, tissue engineering, and gene therapy rely on stable and controlled culture environments. Automated systems help standardize these processes, ensuring better outcomes and scalability for advanced treatments. Moreover, automation allows labs to handle more samples, reducing turnaround time and increasing productivity. As precision medicine gains traction, automated cell shakers are becoming essential tools in clinical and translational research workflows.
Automated Cell Shakers Market Report Highlights
- Based on product, the orbital shakers segment is expected to witness the fastest growth, with a CAGR of 9.18% during the forecast period, due to the increasing preference for uniform and efficient cell culture agitation. These devices are widely used in laboratories because they maintain consistent mixing and reduce contamination risk. Their compatibility with various vessel sizes and formats supports flexible experimental setups. The rising need for high-throughput screening in biotechnology and pharmaceutical research further drives the demand. Integrating programmable speed controls and digital interfaces enhances ease of use and process reproducibility. Advancements in motor technology have also improved energy efficiency and durability in these systems.
- Based on application, the drug development segment dominated the market and accounted for the largest revenue share in 2024, driven by the rising focus on precision medicine and biologics. Automated cell shakers are vital in culturing cells used in early-stage drug discovery and efficacy testing. The segment benefits from the growing volume of clinical trials and the increasing complexity of compound screening. Pharmaceutical firms require reliable systems that support consistent cell viability and reduce manual handling. These devices also help maintain optimal growth environments, improving the speed and accuracy of experimental results. The need for scalable and reproducible workflows continues to push demand within this segment.
- Based on end use, the pharmaceutical companies segment held the largest revenue share in 2024, driven by the increasing demand for streamlined bioprocessing in cell-based studies. These companies rely on automated cell shakers for consistent cell culture preparation during research and production. The shift toward automation across lab operations supports time savings and reduces errors in experimental outcomes. The growing pipeline of biologics and biosimilars has further expanded the usage of automated systems for cell expansion. These devices enhance throughput and reduce variability in large-scale production settings. The segment continues to grow with rising investment in R&D infrastructure across pharmaceutical firms.
- North America held the largest market share of 37.49% in 2024 in the automated cell shakers market, primarily driven by the strong presence of the pharmaceutical and biotechnology industries. The region has a high concentration of research institutes and academic centers using automated systems for advanced cell studies. Continuous innovation and adoption of automated lab technologies support market leadership in North America.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Automated Cell Shakers Market Variables & Trends
Chapter 4. Automated Cell Shakers Market: Product Estimates & Trend Analysis
Chapter 5. Automated Cell Shakers Market: Application Estimates & Trend Analysis
Chapter 6. Automated Cell Shakers Market: End Use Estimates & Trend Analysis
Chapter 7. Automated Cell Shakers Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this Automated Cell Shakers market report include:- Thermo Fisher Scientific Inc.
- Eppendorf AG
- Ohaus Corporation
- Benchmark Scientific
- Corning Incorporated
- Grant Instruments
- Kuhner Shaker
- Infors AG
- Boekel Scientific
- VELP Scientifica Srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 698.9 Million |
| Forecasted Market Value ( USD | $ 1050 Million |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
